Floatz logo

DEXAMETHASONE

Neoplasms

Hellenic Society of HematologySmall moleculePhase 3Active
BB
66/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
66/ 100
Competitive Position
65/ 100

Competitive context

118 Active assets in the Neoplasms cohort.

Asset / SponsorPhaseRating
Feladilimab
GlaxoSmithKline
Phase 2BB
Carboplatin
Bristol-Myers Squibb
Phase 3BB
Cetuximab
Mirati Therapeutics Inc.
Phase 4B
PREDNISONE TABLETS
The First Affiliated Hospital of Soochow University
Phase 3B
Letrozole
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Phase 2B

View all 50 →

Same molecule, other indications

DEXAMETHASONE is also rated in:

chemotherapy-induced toxicityDormant
A
Indicative ·
82 / 100
View asset →
adult acute lymphoblastic leukemiaDormant
BBB
Indicative ·
79 / 100
View asset →
B-cell childhood acute lymphoblastic leukemiaDormant
BBB
Indicative ·
78 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →